Paclitaxel Ever Valinject

Paclitaxel, the active ingredient in Paclitaxel Ever Valinject, is a taxane presented as a sterile injectable solution for intravenous use. It is employed in the treatment of various malignant tumors, particularly breast, ovarian, and non‑small cell lung cancers, in adult patients. GNH USA supplies Paclitaxel Ever Valinject as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres and hospitals worldwide.

Paclitaxel is a chemotherapeutic agent that interferes with cell growth and the mitotic process for several cancers of the breast and the lung and ovary ​​: - Breast cancer: It makes the tumor shrink and slow the  ​        ...  .... ... …  t  .... .... ... ... ... ... ... ... ... ... ... ... ... … . -  ... … ... .... ... ... ... ... ... … . -  .... .... ...

  .... ....  ...

{"...":null}